Verition Fund Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $178K | Sell |
30,766
-63,665
| -67% | -$367K | ﹤0.01% | 2654 |
|
2025
Q1 | $623K | Sell |
94,431
-21,163
| -18% | -$140K | ﹤0.01% | 1858 |
|
2024
Q4 | $1.01M | Buy |
115,594
+27,199
| +31% | +$237K | ﹤0.01% | 1530 |
|
2024
Q3 | $1.73M | Sell |
88,395
-101,614
| -53% | -$1.99M | 0.01% | 1059 |
|
2024
Q2 | $3.91M | Sell |
190,009
-171,811
| -47% | -$3.54M | 0.02% | 614 |
|
2024
Q1 | $7.72M | Sell |
361,820
-103,773
| -22% | -$2.21M | 0.05% | 371 |
|
2023
Q4 | $6.7M | Buy |
+465,593
| New | +$6.7M | 0.05% | 320 |
|
2022
Q4 | – | Sell |
-576,240
| Closed | -$7.87M | – | 1953 |
|
2022
Q3 | $7.87M | Buy |
576,240
+38,153
| +7% | +$521K | 0.09% | 232 |
|
2022
Q2 | $9.86M | Buy |
538,087
+44,949
| +9% | +$824K | 0.2% | 93 |
|
2022
Q1 | $7.93M | Buy |
+493,138
| New | +$7.93M | 0.1% | 157 |
|
2021
Q4 | – | Sell |
-77,749
| Closed | -$1.46M | – | 2004 |
|
2021
Q3 | $1.46M | Sell |
77,749
-202,337
| -72% | -$3.79M | 0.01% | 575 |
|
2021
Q2 | $5.84M | Buy |
280,086
+85,001
| +44% | +$1.77M | 0.05% | 156 |
|
2021
Q1 | $5.52M | Buy |
195,085
+51,788
| +36% | +$1.46M | 0.06% | 126 |
|
2020
Q4 | $4.68M | Buy |
143,297
+85,776
| +149% | +$2.8M | 0.04% | 148 |
|
2020
Q3 | $1.76M | Buy |
+57,521
| New | +$1.76M | 0.04% | 223 |
|